Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cited by (1,006)

Items 301–400 of 1,006

1. A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes
   Ting-You Wang, Qi Liu, Yanan Ren, Sk. Kayum Alam, Li Wang, Zhu Zhu, Luke H. Hoeppner, Scott M. Dehm, Qi Cao, Rendong Yang · 2021 · Molecular Cell
2. Riluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review)
   Angelina Blyufer, Sonam Lhamo, Cassey Tam, Iffat Tariq, Thongthai Thavornwatanayong, Shahana S. Mahajan · 2021 · International Journal of Oncology
3. Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks
   Ke Xu, Jie Ma, Sean R. R. Hall, Ren‐Wang Peng, Haitang Yang, Feng Yao · 2023 · Theranostics
4. The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
   Sen Wang, Yudong Qiu, Bing Bai · 2019 · Frontiers in Oncology
5. Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma
   Wang, Biao, Peng, Fu, Huang, Wei, Zhou, Jin, Zhang, Nan, Sheng, Jia, Haruehanroengra, Phensinee, He, Gu, Han, Bo · 2020 · Acta Pharmaceutica Sinica B
6. Integrating chemical and mechanical signals through dynamic coupling between cellular protrusions and pulsed ERK activation
   Jr-Ming Yang, Sayak Bhattacharya, Hoku West‐Foyle, Chien‐Fu Hung, T.‐C. Wu, Pablo A. Iglesias, Chuan‐Hsiang Huang · 2018 · Nature Communications
7. METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma
   Ye Lin, Xiangling Wei, Zhixiang Jian, Xuewen Zhang · 2020 · Cancer Medicine
8. The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers
   Yaodong Zhang, Zijian Ma, Changxian Li, Cheng Wang, Wangjie Jiang, Jiang Chang, Sheng Han, Zefa Lu, Zicheng Shao, Yirui Wang et al. · 2022 · Nature Communications
9. Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
   Shen Zhao, De-Pin Chen, Tong Fu, Jingcheng Yang, Ding Ma, Xiu-Zhi Zhu, Xiang-Xue Wang, Yiping Jiao, Xi Jin, Yi Xiao et al. · 2023 · Nature Communications
10. Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma
    Xiaonan Xi, Yahui Chu, Ning Liu, Qianqian Wang, Zheng Yin, Yaxin Lu, Yue Chen · 2019 · Journal of Translational Medicine
11. Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity
    Courtney Mowat, Jasmine Dhatt, Ilsa Bhatti, Angela Hamie, Kristi Baker · 2023 · Frontiers in Immunology
12. Discovery of KRAS(G12D) selective degrader ASP3082
    Tomohiro Yoshinari, Takeyuki Nagashima, Hiroki Ishioka, Kohei Inamura, Yoshihiro Nishizono, Mamoru Tasaki, Kanako Iguchi, Atsushi Suzuki, Chikako Sato, Ayako Nakayama et al. · 2025 · Communications Chemistry
13. Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
    Shuang George Zhao, William S. Chen, Rajdeep Das, Sei‐Won Laura Chang, Scott A. Tomlins, Jonathan Chou, David Alan Quigley, Ha X. Dang, Travis J. Barnard, Brandon Arvin Virgil Mahal et al. · 2018 · Clinical Cancer Research
14. Metabolic regulation of the cancer-immunity cycle
    Luis F. Somarribas Patterson, Santosha Adipudi Vardhana · 2021 · Trends in Immunology
15. Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
    Evan Barry, Vladimir Simov, Iris Valtingojer, Olivier Venier · 2021 · Cells
16. Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer
    Sebastián Mondaca, Henry S. Walch, Subhiksha Nandakumar, Walid Khaled Chatila, Nikolaus D. Schultz, Rona D. Yaeger · 2020 · Gastroenterology
17. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Journal of Hematology & Oncology
18. Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications
    Kit-Yee Wong, A. Cheung, Bo-Nan Chen, Wai-Nok Chan, Jun Yu, Kwok-Wai Lo, Wei Kang, Ka-Fai To · 2022 · International Journal of Cancer
19. Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies
    Joan Montero, Cécile Gstalder, Daniel J. Kim, Dorota E. Sadowicz, Wayne O. Miles, Michael P. Manos, Justin R. Cidado, John Paul Secrist, Adriana E. Tron, Keith T. Flaherty et al. · 2019 · Nature Communications
20. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping
    Anita Sathyanarayanan, Rohit Gupta, Erik W. Thompson, Dale R. Nyholt, Denis C. Bauer, Shivashankar Hiriyur Nagaraj · 2019 · Briefings in Bioinformatics
21. Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration
    Saba Ubaid, Rashmi Kushwaha, Mohammad Kashif, Vivek Kumar Singh · 2025 · Cancer Genetics
22. Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies
    Maria John Newton Amaldoss, Jia‐Lin Yang, Pramod Koshy, Ashwin Unnikrishnan, Charles Christopher Sorrell · 2022 · Drug Discovery Today
23. Integrative proteogenomic characterization of early esophageal cancer
    Li, Lingling, Jiang, Dongxian, Zhang, Qiao, Liu, Hui, Xu, Fujiang, Guo, Chunmei, Qin, Zhaoyu, Wang, Haixing, Feng, Jinwen, Liu, Yang et al. · 2023 · Nature Communications
24. Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis
    Anna Skakodub, Henry S. Walch, Kathryn Ries Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan, Bob T. Li, Nelson S. Moss, Kenny Kwok Hei Yu, Boris A. Mueller et al. · 2023 · Nature Communications
25. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
    Dong Ha Kim, Hyojeong Park, Yun Jung Choi, Kyungtaek Im, Chae Won Lee, Da-Som Kim, Chan‐Gi Pack, Hyun‐Yi Kim, Chang‐Min Choi, Jae Cheol Lee et al. · 2023 · Biomarker Research
26. Signaling from RAS to RAF: The Molecules and Their Mechanisms
    Hyesung Jeon, Emre Tkacik, Michael J. Eck · 2024 · Annual Review of Biochemistry
27. Advancing precision oncology with AI-powered genomic analysis
    Ruby Srivastava · 2025 · Frontiers in Pharmacology
28. The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer
    Warren Wu, Thales Y. Papagiannakopoulos · 2020 · Annual Review of Cancer Biology
29. Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
    Yan Xu · 2018 · Cancers
30. Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
    Junyu Long, Dongxu Wang, Xu Yang, Anqiang Wang, Yu Syuan Lin, Mingjun Zheng, Haohai Zhang, Xinting Sang, Hanping Wang, Ke Hu et al. · 2021 · BMC Medicine
31. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes
    Naser Ansari‐Pour, Yonglan Zheng, Toshio F. Yoshimatsu, Ayodele Sanni, Mustapha Ajani, Jean-Baptiste Reynier, Avraam Tapinos, Jason J. Pitt, Stefan C. Dentro, Anna Woodard et al. · 2021 · Nature Communications
32. Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
    Xiaofan Lu, Jialin Meng, Liwen Su, Liyun Jiang, Haitao Wang, Junkai Zhu, Mengjia Huang, Wenxuan Cheng, Li Xu, Xinjia Ruan et al. · 2021 · Clinical and Translational Medicine
33. Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways
    Pham, Trang H., Hagenbeek, Thijs J., Lee, Ho-June, Li, Jason, Rose, Christopher M., Lin, Eva, Yu, Mamie, Martin, Scott E., Piskol, Robert, Lacap, Jennifer A. et al. · 2021 · Cancer Discovery
34. Fatty Acids and Membrane Lipidomics in Oncology: A Cross-Road of Nutritional, Signaling and Metabolic Pathways
    Carla Ferreri, Anna Sansone, Ferreri Rosaria, Javier Amézaga, Itziar Tueros · 2020 · Metabolites
35. Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
    Yu-Wei Li, Lei-Jie Dai, Xiangrong Wu, Shen Zhao, Yu-Zheng Xu, Xi Jin, Yi Xiao, Ying Wang, Cai‐Jin Lin, Yi-Fan Zhou et al. · 2024 · Cancer Research
36. Progress in targeting RAS with small molecule drugs
    Frank P. McCormick · 2019 · Biochemical Journal
37. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary
    Arnaud Da Cruz Paula, Edaise M. da Silva, Sheila E. Segura, Fresia G. Pareja, Rui Bi, Pier Selenica, Sarah H. Kim, Lorenzo Ferrando, Mahsa Vahdatinia, Robert A. Soslow et al. · 2020 · Modern Pathology
38. Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q
    Jasper Edgar Neggers, Brenton R. Paolella, Adhana Asfaw, Michael V. Rothberg, Thomas A. Skipper, Annan Yang, Radha L. Kalekar, John Michael Krill-Burger, Neekesh V. Dharia, Guillaume Kugener et al. · 2020 · Cell Reports
39. Understanding Cervical Cancer through Proteomics
    Fátima Martínez-Rodríguez, Jared E. Limones-González, Brenda Mendoza-Almanza, Edgar L. Esparza-Ibarra, Perla Ivonne Gallegos-Flores, Jorge Luis Ayala-Luján, Susana Godina-González, Eva Salinas, Gretel Mendoza‐Almanza · 2021 · Cells
40. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
    Li Guan, Dhanya K. Nambiar, Hongbin Cao, Vignesh Viswanathan, Shirley Kwok, Angela Bik‐Yu Hui, Yuan Hou, Rachel Hildebrand, Rie von Eyben, Brittany Holmes et al. · 2023 · Cancer Research
41. Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling
    Xiaoyu Yuan, Kelie Chen, Fang Zheng, Sinan Xu, Yating Li, Yuwei Wang, Heng Ni, Fang Wang, Zhenyan Cui, Yuheng Qin et al. · 2023 · Journal of Hazardous Materials
42. Targeting the Hippo pathway in cancer
    Kieran F. Harvey, Tracy Tzu-Ling Tang · 2025 · Nature Reviews Drug Discovery
43. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
    Yong Suk Cho, Shuang Li, Xiaohui Wang, Jian Zhu, Shu Zhuo, Yuhong Han, Tao Yue, Yingzi Yang, Jin Jiang · 2019 · Genes & Development
44. Therapeutic cancer vaccines revamping: technology advancements and pitfalls
    Gabriele Antonarelli, Chiara Corti, Paolo Tarantino, Liliana Ascione, Javier Cortés, Pedro J. Romero, EA Mittendorf, Mary Lenora Disis, Giuseppe Curigliano · 2021 · Annals of Oncology
45. Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
    Manojit Mosur Swamynathan, Shan Kuang, Kaitlin E. Watrud, Mary R. Doherty, Charlotte Gineste, Grinu Mathew, Grace Qun Gong, Hilary Cox, Eileen Cheng, David J. Reiss et al. · 2024 · Science
46. Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of β-catenin
    Jin Yan, Heyuan Liu, Wenguang Yang, Na Liu, Jingmei Wang, Zhanfeng Li, Tianya Liu, Siqi Yan, Wangxiao He · 2025 · Nature Communications
47. Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction
    Jianbo Tian, Jiang Chang, Jing Gong, Jiao Lou, Mingpeng Fu, Jiaoyuan Li, Juntao Ke, Ying Zhu, Yajie Gong, Yang Yang et al. · 2019 · The American Journal of Human Genetics
48. Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer
    Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung‐Ho Pyo, Eun Joo Shin et al. · 2019 · EMBO Molecular Medicine
49. The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer
    Zongsheng He, Lieven Thorrez, Géraldine Siegfried, Sandra M.P. Meulemans, Serge Évrard, Sabine Tejpar, Abdel‐Majid Khatib, John W.M. Creemers · 2020 · Oncogene
50. PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
    Cathalijne Post, Anneke M. Westermann, Tjalling Bosse, Carien L. Creutzberg, Judith R. Kroep · 2020 · Critical Reviews in Oncology/Hematology
51. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
    Florence Coussy, Rania El Botty, Marion Lavigne, Céline Gu, Laetitia Fuhrmann, Adrien Briaux, Leanne de Koning, A. Dahmani, Élodie Montaudon, Ludivine Morisset et al. · 2020 · Journal of Hematology & Oncology
52. An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
    Milan Teraiya, Hélène Perreault, Vincent C. Chen · 2023 · Frontiers in Oncology
53. Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies
    Robert Jr. Roskoski · 2021 · Pharmacological Research
54. Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy
    Di Xia, Xiaoran Zhang, Yanli Ma, Zhijun Zhao, Ren Zhao, Yanyang Wang · 2020 · Cell & Bioscience
55. Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors
    Konrad Hermann Stopsack, Subhiksha Nandakumar, Kanika S. Arora, Bastien Nguyen, Samantha E. Vasselman, Barbara Nweji, Sean Matthew McBride, Michael J. Morris, Dana E. Rathkopf, Susan F. Slovin et al. · 2021 · Clinical Cancer Research
56. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Walid Khaled Chatila, Henry S. Walch, Jaclyn Frances Hechtman, Sydney M. Moyer, Valeria Sgambati, David M. Faleck, Amitabh Srivastava, Laura H. Tang, Jamal K. Benhamida, Dorina Ismailgeci et al. · 2023 · Nature Communications
57. Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker
    Shihua Dong, Wei Li, Lin Wang, Jie Hu, Yuanlin Song, Baolong Zhang, Xiaoguang Ren, Shimeng Ji, Jin Li, Peng Xu et al. · 2019 · Cancer Research
58. Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target
    Ricardo Gargini, Berta Segura‐Collar, Pilar Sánchez‐Gómez · 2020 · Cancers
59. Recent trends in biodegradable polyester nanomaterials for cancer therapy
    Piyush Kumar Gupta, Rekha Gahtori, Kavitha Govarthanan, Vineeta Sharma, Sreenath Pappuru, Soumya Pandit, Abhilasha Singh Mathuriya, Sunny Dholpuria, Dillip Kumar Bishi · 2021 · Materials Science and Engineering C
60. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
    Jo Waaler, Line Mygland, Anders Aune Tveita, Martin Frank Strand, Nina Therese Solberg, Petter Angell Olsen, Aleksandra Aizenshtadt, Marte Fauskanger, Kaja Lund, Shoshy Alam Brinch et al. · 2020 · Communications Biology
61. Overview of Morin and Its Complementary Role as an Adjuvant for Anticancer Agents
    Solaipriya Solairaja, Mohammad Qasim Andrabi, Nageswara Rao Dunna, Sivaramakrishnan Venkatabalasubramanian · 2020 · Nutrition and Cancer
62. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
    Mingjun Shi, Xiangyu Meng, Jacqueline Fontugne, Chun-Long Chen, François Radvanyi, Isabelle Bernard‐Pierrot · 2020 · Genome Medicine
63. Chemopreventive effects of anthocyanins on colorectal and breast cancer: A review
    David Bars‐Cortina, Ali Sakhawat, Carme Piñol, María‐José Motilva · 2021 · Seminars in Cancer Biology
64. A large collection of integrated genomically characterized patient‐derived xenografts highlighting the heterogeneity of triple‐negative breast cancer
    Florence Coussy, Leanne de Koning, Marion Lavigne, Virginie Bernard, Bérengère Ouine, Anaïs Boulai, Rania El Botty, Ahmed Dahmani, Élodie Montaudon, Franck Assayag et al. · 2019 · International Journal of Cancer
65. Hypomethylation‐mediated activation of cancer/testis antigen KK‐LC‐1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling
    Zhiqiang Chen, Xueliang Zuo, Liyong Pu, Yao Zhang, Guoyong Han, Long Zhang, Zhengshan Wu, Wei You, Jianjie Qin, Xinzheng Dai et al. · 2019 · Cell Proliferation
66. Predicting Anticancer Drug Response With Deep Learning Constrained by Signaling Pathways
    Heming Zhang, Yixin Chen, Fuhai Li · 2021 · Frontiers in Bioinformatics
67. Machine learning analysis of TCGA cancer data
    José Liñares-Blanco, Alejandro Pazos, Carlos Fernandez-Lozano · 2021 · PeerJ Computer Science
68. A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
    Choong‐kun Lee, Sun Young Rha, Hyo Song Kim, Minkyu Jung, Beodeul Kang, Jingmin Che, Woo Sun Kwon, Sejung Park, Woo Kyun Bae, Dong‐Hoe Koo et al. · 2022 · Nature Communications
69. Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer
    Firoz Ahmed · 2019 · Frontiers in Oncology
70. Exploring Dysregulated Signaling Pathways in Cancer.
    Sabah Nisar, Sheema Hashem, M. Macha, S. Yadav, S. Muralitharan, Lubna Therachiyil, Geetanjali Sageena, H. Al-Naemi, Mohammad Haris, A. Bhat · 2020 · Current pharmaceutical design
71. Emerging Therapeutic Implications of STK11 Mutation: Case Series
    Bahar Laderian, Prabhjot Singh Mundi, Tito Fojo, Susan Elaine Bates · 2020 · The Oncologist
72. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
    Apostolos Klinakis, Theodoros N Rampias · 2020 · EBioMedicine
73. Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2
    Liam Baird, Takafumi Suzuki, Yu Takahashi, Eiji Hishinuma, D. Saigusa, M. Yamamoto · 2020 · Molecular and Cellular Biology
74. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
    Evan Rosenbaum P. E, Cristina R. Antonescu, Shaleigh A. Smith, Martina Bradić, Daniel Kashani, Allison L. Richards, Mark T.A. Donoghue, Ciara Marie Kelly, Benjamin Alexander Nacev, Jason Earl Chan et al. · 2022 · Journal for ImmunoTherapy of Cancer
75. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma
    Shixue Yang, Jixing Zhao, Xiaoteng Cui, Qi Zhan, Kaikai Yi, Qixue Wang, Menglin Xiao, Yanli Tan, Biao Hong, Chuan Fang et al. · 2022 · Theranostics
76. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer
    Yoann Pradat, Julien Viot, Гунбин Константин Владимирович, Гунбин Константин Владимирович, Luigi Cerbone, Marc Deloger, Guillaume Grisay, Loïc Verlingue, Véronique Scott, Ismaël Padioleau et al. · 2023 · Cancer Discovery
77. Prediction of breast cancer proteins involved in immunotherapy, metastasis, and RNA-binding using molecular descriptors and artificial neural networks
    Andrés López‐Cortés, Alejandro Cabrera‐Andrade, José M. Vázquez-Naya, Alejandro Pazos, Humberto González‐Díaz, César Paz‐y‐Miño, Santiago Xavier Guerrero, Yunierkis Pérez‐Castillo, Eduardo Tejera, Cristian Robert Munteanu · 2020 · Scientific Reports
78. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder
    Kaiwei Yang, Wei Yu, Huanhuan Liu, Feng Ding, Yanrui Zhang, Yun Zhang, Wang Wang, Feng Lou, Shanbo Cao, Huina Wang et al. · 2021 · The Oncologist
79. Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms
    Charles W. Abbott, Sean M. Boyle, Rachel Marty Pyke, Lee McDaniel, Éric Levy, Fábio C. P. Navarro, Dattatreya Mellacheruvu, Simo V. Zhang, Mengyao Tan, Rose Santiago et al. · 2021 · Clinical Cancer Research
80. Chronic expression of p16INK4a in the epidermis induces Wnt-mediated hyperplasia and promotes tumor initiation
    Azazmeh, Narmen, Assouline, Benjamin, Winter, Eitan, Ruppo, Shmuel, Nevo, Yuval, Maly, Alexander, Meir, Karen, Witkiewicz, Agnieszka K., Cohen, Jonathan, Rizou, Sophia V. et al. · 2020 · Nature Communications
81. Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis
    Josef Leibold, Marcus A. Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou, Wassim M. Abida, Judith Feucht, Teng Han, Francisco M. Barriga et al. · 2020 · Cancer Discovery
82. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer
    Meng Qi, Yun‐Xin Lu, Dan‐Yun Ruan, Kai Yu, Yan‐Xing Chen, Min Xiao, Yun Wang, Zexian Liu, Rui‐Hua Xu, Huai‐Qiang Ju et al. · 2021 · Molecular Therapy — Nucleic Acids
83. Functions and Targets of miR-335 in Cancer
    Lingling Ye, Fen Wang, Hao Wu, Hui Yang, Yan T. Yang, Yajun Ma, Aili Xue, Jing Zhu, Meili Chen, Jinyan Wang et al. · 2021 · OncoTargets and Therapy
84. A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
    Junyu Long, Dongxu Wang, Anqiang Wang, Peipei Chen, Yu Syuan Lin, Jin‐Song Bian, Xu Yang, Mingjun Zheng, Haohai Zhang, Yongchang Zheng et al. · 2022 · Genome Medicine
85. Heterogeneity in Melanoma
    Mei Fong Ng, Jacinta L. Simmons, Glen M. Boyle · 2022 · Cancers
86. Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
    Ellen R. Langille, Khalid N. Al‐Zahrani, Zhibo Ma, Minggao Liang, Liis Uusküla-Reimand, Roderic Espín, Katie Teng, Ahmad Malik, Helga Bergholtz, Samah El Ghamrasni et al. · 2022 · Cancer Discovery
87. Structural basis of transcription regulation by CNC family transcription factor, Nrf2
    Toru Sengoku, Masaaki Shiina, Kae Suzuki, Keisuke Hamada, Ko Sato, Akiko Uchiyama, Shunsuke Kobayashi, Asako Oguni, Hayato Itaya, Kota Kasahara et al. · 2022 · Nucleic Acids Research
88. The fibroinflammatory response in cancer
    Zebin Xiao, Ellen Puré · 2025 · Nature reviews. Cancer
89. Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
    Michiel Remmerie, Veerle Janssens · 2018 · International Journal of Molecular Sciences
90. Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
    Makiko Hayashi, Ayumi Kuga, Mikiko Suzuki, Harit Panda, Hiroshi Kitamura, Hozumi Motohashi, Masayuki P. Yamamoto · 2020 · Cancer Research
91. KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples
    Herbert Ho-Fung Loong, Nan Du, Chunyan Cheng, Hanqing Lin, Jian Guo, Gen Lin, Mingjiang Li, Tao Jiang, Zhihua Shi, Yanzhi Cui et al. · 2020 · Translational Lung Cancer Research
92. Oncoviruses Can Drive Cancer by Rewiring Signaling Pathways Through Interface Mimicry
    Emine Guven‐Maiorov, Chung‐Jung Tsai, Ruth Nussinov · 2019 · Frontiers in Oncology
93. Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a Toxicology Forum state-of-the-science workshop
    Susan P. Felter, Virunya S. Bhat, Philip A. Botham, David A. Bussard, Warren Casey, Andrew Wallace Hayes, Gina M. Hilton, Kelly A. Magurany, Ursula G. Sauer, Edward V. Ohanian · 2021 · Critical Reviews in Toxicology
94. Modulated Ultrasmall γ‐Fe2O3 Nanocrystal Assemblies for Switchable Magnetic Resonance Imaging and Photothermal‐Ferroptotic‐Chemical Synergistic Cancer Therapy
    Bao-Chan Yang, Yiming Zhang, Li-Xin Sun, Jian Wang, Zunling Zhao, Zhuoyue Huang, Wei Mao, Rong Xue, Run-Sheng Chen, Jian-Jun Luo et al. · 2022 · Advanced Functional Materials
95. Precision medicine review: rare driver mutations and their biophysical classification
    Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng · 2019 · Biophysical Reviews
96. TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
    Hui Juan Lu, Juanjuan Xiao, Changshu Ke, Xiaofang Ni, Ruijuan Xiu, Qin Tian, Huaxiong Pan, Ling Zou, Fei Wang, Tengfei Ma et al. · 2019 · Cell Death and Disease
97. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT
    Hongyang Yi, Guipeng Li, Yongkang Long, Weizheng Liang, Huanhuan Cui, Bin Zhang, Ying Tan, Yunfei Li, Luochen Shen, Daqi Deng et al. · 2020 · Oncogene
98. Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel
    Ali Saeed Alzahrani, Meshael M. Alswailem, Anwar Ali Alswailem, Hindi Al‐Hindi, Ewa Goljan, Nourah Alsudairy, Mohamed Ibrahim Abouelhoda · 2020 · The Journal of Clinical Endocrinology & Metabolism
99. Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights
    Olusegun Isaac Alatise, Gregory Knapp, Avinash S. Sharma, Walid Khaled Chatila, Olukayode Adeolu Arowolo, Olalekan O. Olasehinde, Olusola Comfort Famurewa, Adeleye Dorcas Omisore, Akinwumi Oluwole Komolafe, Olaejirinde Olaniyi Olaofe et al. · 2021 · Nature Communications
100. Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma
     Feng Qi, Jia Li, Zhuoran Qi, Jian Zhang, Bin Zhou, Biwei Yang, Wenxing Qin, Wenguo Cui, Jinglin Xia · 2023 · Research